Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Theracryf PLC Directors Deals (TCF)
Dr Huw Jones, CEO of TheraCryf plc, on Positive Ox-1 Toxicology Data, Commercial Partner Interest and the Path to Human Trials
TCF Share
Price
TCF Share
News
TCF Share
Chat
TCF Share
Trades37
TCF
Live RNS
TCF Share
Charts
TCF Level 2
Console
TCF Live
Share Price
TCF Broker
Ratings
TCF Directors
Deals
TCF Financial
Diary
TCF
Fundamentals
TCF Short
Positions
TCF
Media1
TCF Company
Research
TCF Company
Timeline1
Theracryf PLC Information
Share Price Information for Theracryf PLC (TCF)
Share Price is delayed by 15 minutes
Get Live Data
0.235
-0.01 (-4.08%)
Bid:
0.23
Ask:
0.24
Spread:
0.01 (4.348%)
Market Cap:
£5.05m
Last checked at -
Last checked at 
Intraday Theracryf PLC Share Chart
Directors Deals for Theracryf PLC (TCF)
| Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
|---|---|---|---|---|---|---|---|
| 16-Oct-25 | 14-Oct-25 | Buy | Edward Wardle held the position of Non-Executive Director at the time of this trade.Edward Wardle | 0.18 | GBX | 7,342,296 | 7,342,296 |
Follow the stocks
